1 - 8 of 8 articles
The Legal Action Center (LAC) presentation at this year's American Association for the Treatment of Opioid Dependence (AATOD) conference (held virtually in April) focused on barriers to Medicare coverage for treatment for substance use disorders (SUDs). Coming on the heels of the approval by the...
Operating with less national fanfare than the prominent public debate over reforming police practices, a nonprofit initiative that began in Massachusetts in 2015 continues to build toward its mission to make nonarrest diversion a standard law enforcement practice nationally.
The emotional rewards of alcohol, however difficult to quantify, have long been accepted as a key factor in reinforcing problematic drinking. Survey methods have traditionally used participant recall of experiences, suggesting that self‐reported motivations predict problem drinking. Enhancing of...
This month, the Food and Drug Administration (FDA) approved samidorphan and olanzapine, a new combination medication, for the treatment of schizophrenia and bipolar disorder. The medication sponsor is Alkermes, and the medication is called Lybalvi.
Last week, the National Institute on Drug Abuse (NIDA) announced a clinical trial to look at the effectiveness of mobile vans in distributing buprenorphine, naloxone, syringe services, HIV testing, HIV treatment using antiretroviral therapy, PrEP for HIV prevention, and testing for hepatitis and...
Virtual: The annual conference of the College on Problems of Drug Dependence will be held June 21‐24. For more information, go to https://cpdd.org/.
States really want to get constituents vaccinated against COVID‐19. Constituents are sometimes resistant, so some states have arrived at the obvious solution: free alcohol and marijuana. Is this a mixed message? The states say “Who cares?” A little intoxication is a lot better than massive...
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.